In addition to cDC1s, which orchestrate the cross-talk between CD4 and CD8 T cells to achieve a potent T cell response, plasmacytoid dendritic cells (pDCs) are emerging as important regulators of anti-tumor responses. The gene discussed is CD8A; the disease is neoplasm.